Big Pharma Split Corp. Share Price

Equities

PRM

CA08934P1080

Mutual Funds

Delayed Toronto S.E. 12:31:47 02/05/2024 am IST 5-day change 1st Jan Change
13.85 CAD +1.61% Intraday chart for Big Pharma Split Corp. +2.59% +0.73%

Financials

Sales 2022 6.65M 4.86M 405M Sales 2023 321K 234K 19.54M Capitalization 16.76M 12.25M 1.02B
Net income 2022 2M 1.46M 122M Net income 2023 - 0 0 EV / Sales 2022 4.68 x
Net Debt 2022 9.04M 6.6M 550M Net Debt 2023 10.09M 7.38M 615M EV / Sales 2023 83.7 x
P/E ratio 2022
9.21 x
P/E ratio 2023
-25.9 x
Employees -
Yield 2022
8.49%
Yield 2023
9%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Big Pharma Split Corp. Declares April 2024 Distribution, Payable on May 9, 2024 CI
Big Pharma Split Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Big Pharma Split Corp. Declares March 2024 Distributions, Payable on April 9, 2024 CI
Big Pharma Split Corp. Declares February 2024 Distributions, Payable on March 8, 2024 CI
Harvest Portfolios Group Inc. Declares Big Pharma Split Corp. Class A Special Capital Gains Distribution, Payable on February 26, 2024 CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Each Class A Share for the Month Ending January 31, 2024, Payable February 9, 2024 CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Month Ending December 31, 2023, Payable on January 9, 2024 CI
Big Pharma Split Corp. Declares Monthly Cash Distribution for Month Ending November 30, 2023, Payable on December 8, 2023 CI
Big Pharma Split Corp. Announces October 2023 Distribution, Payable November 9, 2023 CI
Big Pharma Split Corp. Declares Monthly Cash Distribution Payable for Each Class A Share for the Month Ending September 30, 2023, Payable October 6, 2023 CI
Big Pharma Split Corp. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Big Pharma Split Corp. Declares Cash Distribution on Class A Share for the Month Ending August 31, 2023, Payable on September 8, 2023 CI
Big Pharma Split Corp. Declares Cash Distribution for the Month Ending July 31, 2023, Payable on August 9, 2023 CI
Big Pharma Split Corp. Declares the Monthly Cash Distribution of June 2023, Payable July 7, 2023 CI
Big Pharma Split Corp. Declares Distribution for the Month Ending May 31, 2023, Payable on June 9, 2023 CI
More news
1 day+1.61%
1 week+2.59%
Current month+1.61%
3 months-3.69%
6 months+3.90%
Current year+0.73%
More quotes
1 week
13.63
Extreme 13.63
13.85
1 month
13.20
Extreme 13.2
14.13
Current year
13.20
Extreme 13.2
14.75
1 year
13.20
Extreme 13.2
15.35
3 years
12.50
Extreme 12.5
16.77
5 years
8.12
Extreme 8.12
16.77
10 years
8.12
Extreme 8.12
16.77
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - -
Director/Board Member - -
More insiders
Date Price Change Volume
01/24/01 13.85 +1.61% 1,072
29/24/29 13.63 0.00% 106
26/24/26 13.63 +0.96% 870
25/24/25 13.5 0.00% 100
24/24/24 13.5 +0.52% 200

Delayed Quote Toronto S.E., May 02, 2024 at 12:31 am IST

More quotes
Big Pharma Split Corp. is a Canada-based investment fund. The Company’s investment objectives for the Preferred shares are to provide their holders with fixed cumulative preferential quarterly cash distributions in the amount of $0.125 per Preferred share and to return the original issue price of $10.00 to holders on the maturity date. Its investment objectives for the Class A shares are to provide their holders with regular monthly non-cumulative cash distributions targeted to be $0.1031 per Class A share representing a yield on the issue price of the Class A shares of 8.25% per annum on the issue price of $15.00 per Class A share and to provide holders with the opportunity for growth in the net asset value per Class A share. It will invest in an initially equally weighted portfolio (the Portfolio) comprised of Equity Securities of ten issuers, selected by the portfolio manager from the investable universe. Its portfolio manager is Harvest Portfolios Group Inc.
More about the company